Product Information

TRIAMCINOLONE ACET 200 MG/5 ML is a generic product labeled by Long Grove Pharmaceuticals, LLC, priced at $6.7336 per ML under NDC 81298578503. Its NADAC has been published 175 times since Jul 19, 2023.

FDA first approved this application on Jan 19, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRIAMCINOLONE ACET 200 MG/5 ML

Triamcinolone Acetonide
$6.7336per ML

Strength

40 mg/mL

NDC

81298578503

Classification

Generic

Dosage Form

SUSPENSION

Route

INTRA-ARTERIAL; INTRAMUSCULAR

Effective Date

11/18/2026

Active Ingredients

TRIAMCINOLONE ACETONIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213543

FDA Approved

1/19/2022

TE Code

AB

On Market Since

5/2/2022

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for TRIAMCINOLONE ACET 200 MG/5 ML has been published 175 times since Jul 19, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$6.7336 per ML
All-time high$6.7336 (Nov 18, 2026)
All-time low$3.9913 (Mar 19, 2025)
52-week high$6.7336
52-week low$5.5980
Median price$5.9956
Average price$5.9214
Largest weekly change-30.7% (Mar 19, 2025)
Weeks tracked175
Tracking sinceJul 19, 2023

Price History

1W

+5.8%

1M

+5.5%

3M

+6.4%

6M

+4.4%

1Y

+20.3%

3Y

+0.9%

5Y

N/A

All

+0.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 29%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRIAMCINOLONE ACET 200 MG/5 ML?

The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE ACET 200 MG/5 ML, manufactured by Long Grove Pharmaceuticals, LLC, is $6.7336 per ML (NDC 81298578503), effective Nov 18, 2026.

How has the price of TRIAMCINOLONE ACET 200 MG/5 ML changed over time?

Over the history we have for it, the NADAC for TRIAMCINOLONE ACET 200 MG/5 ML has held within roughly two percent of its current level. It has been tracked across 175 weekly CMS publications since Jul 19, 2023.

What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE ACET 200 MG/5 ML?

Since Jul 19, 2023, the NADAC for TRIAMCINOLONE ACET 200 MG/5 ML has ranged from a low of $3.9913 (Mar 19, 2025) to a high of $6.7336 (Nov 18, 2026), with a median of $5.9956 per ML.

Are there cheaper alternatives to TRIAMCINOLONE ACET 200 MG/5 ML?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMCINOLONE ACET 400 MG/10 ML, is $4.7510 per ML — about 29% below TRIAMCINOLONE ACET 200 MG/5 ML.

Who manufactures TRIAMCINOLONE ACET 200 MG/5 ML?

TRIAMCINOLONE ACET 200 MG/5 ML (NDC 81298578503) is labeled by Long Grove Pharmaceuticals, LLC, and CMS classifies it as a generic product.